Access to Experimental Drugs in Terminal Illness. Ethical Issues: Udo Schuklenk, New York, Pharmaceutical Products Press, 1998, 228 pages, US$60 [Book Review]

Journal of Medical Ethics 26 (2):148-149 (2000)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1136/jme.26.2.148

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,438

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Terminal illness and access to phase 1 experimental agents, surgeries and devices: Reviewing the ethical arguments.Udo Schüklenk & Christopher Lowry - 2009 - British Medical Bulletin 89 (1):7-22.
An analysis of common ethical justifications for compassionate use programs for experimental drugs.Kasper Raus - 2016 - BMC Medical Ethics 17 (1):60.
Off-trial access to experimental cancer agents for the terminally ill: balancing the needs of individuals and society.M. Chahal - 2010 - Journal of Medical Ethics 36 (6):367-370.
Five words for assisted dying.Iain Brassington - 2008 - Law and Philosophy 27 (5):415 - 444.
Who Should Go First in Trials with Scarce Agents? the Views of Potential Participants.Rebecca D. Pentz, Anne L. Flamm, Jeremy Sugarman, Marlene Z. Cohen, Zhiheng Xu, Roy S. Herbst & James L. Abbruzzese - 2007 - IRB: Ethics & Human Research 29 (4):1.
Patient Access to Experimental Drugs and AIDS Clinical Trial Designs: Ethical Issues.Udo Schüklenk & Carlton Hogan - 1996 - Cambridge Quarterly of Healthcare Ethics 5 (3):400.
Disclosure of terminal illness to patients and families: diversity of governing codes in 14 Islamic countries.H. E. Abdulhameed, M. M. Hammami & E. A. Hameed Mohamed - 2011 - Journal of Medical Ethics 37 (8):472-475.
Drug regulation in the philippines.Allan Grand A. Sobrepena - unknown
First, do no harm: Confronting the myths of psychiatric drugs.P. Barker & P. Buchanan-Barker - 2012 - Nursing Ethics 19 (4):451-463.
The Ethical Issues of Terminal Cancer Patients.Wenhao Su - 2006 - Philosophy and Culture 33 (4):5-15.
Patents and access to drugs in developing countries: An ethical analysis.Sigrid Sterckx - 2004 - Developing World Bioethics 4 (1):58–75.
Global health impact: A basis for labeling and licensing campaigns?Nicole Hassoun - 2012 - Developing World Bioethics 12 (3):121-134.
Can drug patents be morally justified?Dr Sigrid Sterckx - 2005 - Science and Engineering Ethics 11 (1):81-92.
The Phenomenology of Illness.Havi Carel - 2016 - Oxford, United Kingdom: Oxford University Press UK.
Introduction: Access to Life-Saving Medicines and Intellectual Property Rights.Doris Schroeder - 2011 - Cambridge Quarterly of Healthcare Ethics 20 (2):277-278.

Analytics

Added to PP
2010-08-24

Downloads
129 (#139,507)

6 months
1 (#1,498,742)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references